Thyroid-associated antibodies are crucial in the occurrence and development of thyroid-associated ophthalmopathy (TAO). Protein A immunoadsorption is a more specific and plasma-independent antibody removal technology, which has been used in a variety of autoimmune diseases, such as systemic lupus erythematosus and antineutrophil cytoplasmic antibodies associated vasculitis (ANCA-associated vasculitis). This study protocol aims to verify the […]
The post Application of protein A immunoadsorption in thyroid-associated ophthalmopathy (TAO): study protocol for a non-randomised controlled clinical trial. first appeared on Physician’s Weekly.
